Nanoparticulate drug delivery system to overcome the in vivo physiological barriers

来源 :2015年中国药物制剂大会、中国药学会药剂专业委员会2015年学术年会暨国际控释协会中国分会2015年学术年会 | 被引量 : 0次 | 上传用户:RSH1987
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  In vivo application of drug delivery systems faces inevitable challenges of numerous physiological barriers.Overcoming of these barriers often requires very different, or even contradictory properties of a drug delivery vehicle.
其他文献
  Nanoparticle-based drug delivery has emerged as an effective strategy for pharmaceutical formulation and gained particular attention in biomedical field.Nan
会议
  P-glycoprotein (P-gp) overexpression has been validated as the most common cause of multidrug resistance occurrence in clinics.
会议
会议
会议
会议
会议
会议
  Oral administration of drugs is the most common and convenient method.However, the oral bioavailability of hydrophilic macromolecules and peptide and protei
会议
  Protecting proteins from aggregation and maintaining their biological activities is one of the most important issues in both protein science and protein eng
会议